|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:approvalYear
|
1976
|
|
gptkbp:ATCCode
|
gptkb:C07AB03
|
|
gptkbp:bioavailability
|
50% (oral)
|
|
gptkbp:CASNumber
|
gptkb:29122-68-7
|
|
gptkbp:color
|
white
|
|
gptkbp:contraindication
|
asthma
severe bradycardia
cardiogenic shock
second- or third-degree heart block
|
|
gptkbp:eliminationHalfLife
|
6-7 hours
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
gptkbp:form
|
crystalline powder
|
|
gptkbp:hasInChIKey
|
METKIMKYRPQLGS-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C14H22N2O3
|
|
gptkbp:hasPharmacologyAction
|
beta-adrenergic antagonist
|
|
gptkbp:hasSMILES
|
CC(C)NCC(COC1=CC=CC=C1C(=O)N)O
|
|
gptkbp:hasTherapeuticUse
|
gptkb:antiarrhythmic_agent
gptkb:antihypertensive_agent
antianginal agent
|
|
gptkbp:hasUNII
|
50VV3VW0TI
|
|
gptkbp:isApprovedDrug
|
true
|
|
gptkbp:KEGGID
|
gptkb:D00222
|
|
gptkbp:legalStatus
|
prescription only
off-patent
|
|
gptkbp:meltingPoint
|
152-155°C
|
|
gptkbp:MeSH_ID
|
gptkb:D010559
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
266.34
|
|
gptkbp:name
|
gptkb:Atenolol
|
|
gptkbp:originatedIn
|
synthetic
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:proteinBinding
|
6-16%
|
|
gptkbp:PubChem_CID
|
2163
CHEBI:2269
DB00335
2249
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
dizziness
fatigue
bradycardia
cold extremities
gastrointestinal disturbance
|
|
gptkbp:solubility
|
soluble in water
|
|
gptkbp:synonym
|
gptkb:Atenololum
gptkb:Tenormin
|
|
gptkbp:target
|
gptkb:Beta-1_adrenergic_receptor
|
|
gptkbp:bfsParent
|
gptkb:cetirizine
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
CHEMBL1207
|